Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1052)
ARTG (149)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2024 (866)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (6)
2017 (47)
2016 (5)
2015 (29)
2014 (29)
2013 (29)
2012 (23)
2011 (12)
2010 (3)
2009 (8)
2008 (1)
1993 (1)

Results for "[search-keyword]"

Search

Sponsor content

1234 result(s) found, displaying 891 to 900

VEDILOL 6.25 carvedilol 6.25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
VEDILOL 3.125 carvedilol 3.125 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
QUITX nicotine 4mg freshmint coated chewing gum blister pack (new formulation) Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IQUIT Extra Strength nicotine 4mg mint coated chewing gum blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IQUIT Regular Strength nicotine 2mg mint coated chewing gum blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
QUITX nicotine 2mg freshmint coated chewing gum blister pack (new formulation) Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
VEDILOL 12.5 carvedilol 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ANIDULAFUNGIN GX; ANIDULAFUNGIN GA; ANIDULAFUNGIN ISL; ANIDULAFUNGIN JUNO; ANIDULAFUNGIN MEDIS; ANIDULAFUNGIN ZP (Medis Pharma Pty Ltd)

6 January 2022

Prescription medicine registration

Active ingredients: anidulafungin.
PHARMACOR ESOMEPRAZOLE esomeprazole (as magnesium dihydrate) 40 mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 November 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PHARMACOR ESOMEPRAZOLE esomeprazole (as magnesium dihydrate) 20 mg enteric coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

11 November 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 86
Page 87
Page 88
Page 89
Current page 90
Page 91
Page 92
Page 93
Page 94
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.